Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Tumor Biology

Abstract 5149: An orthotopic model of human chordoma in rats

Rachel Sarabia-Estrada, Alejandro Ruiz-Valls, Courtney R. Goodwin, Sagar Sha, Alfredo Quiñones-Hinojosa, Ziya L. Gokaslan and Daniel M. Sciubba
Rachel Sarabia-Estrada
Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Ruiz-Valls
Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Courtney R. Goodwin
Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sagar Sha
Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfredo Quiñones-Hinojosa
Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziya L. Gokaslan
Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel M. Sciubba
Johns Hopkins University, Baltimore, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2015-5149 Published August 2015
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA

Abstract

Introduction. Chordoma (CHO) is a relatively rare, slow-growing, malignant, locally aggressive cancer that constitutes 1% to 4% of all primary bone tumors. It arises from notochordal remnants along the neuraxis at developmentally active sites. CHO causes significant damage through local bone destruction and compromise of surrounding neurologic and neurovascular structures. CHO in the lumbar spine results in devastating effects that include pain, paralysis, bowel/bladder dysfunction, and decreased ambulation. These effects are minimally responsive to conventional chemotherapy and radiotherapy and as such, surgical resection is the mainstay of treatment. Pre-clinical models that better recapitulate the clinical symptoms observed in patients diagnosed with CHO are needed to increase the understanding of this disease and to develop strategies to develop new therapeutic strategies. Here we developed the first orthotopic animal model of human CHO in the lumbar spine of immunocompromised rats.

Methods. 11 immunocompromised rats were implanted in the lumbar spine with human CHO tumor tissue. A group of 6 sham rats (surgical approach without tumor implantation) and another with 6 intact rats were used as control groups. This tumor was obtained from a donor rat that was previously injected with UCH1CHO cells in the flank. Nociceptive response was conducted every week after the first neurological deficits were present using Randal-Sellito. Locomotion gait analysis was used to evaluate gait impairment. Rats were clinically observed for neurological impairment in the lumbar spine and/or hind limbs. Spines were collected after euthanasia, and inspected for signs of spinal cord compression followed by H&E staining to evaluate the histology.

Results. In CHO-implanted rats, the threshold for a mechanic nociceptive response was significantly reduced in time and pressure applied. Locomotion gait analysis showed a disruption in the normal pattern of the rats’ gait. At D25-35 after tumor implantation rats showed impairment in the flexion and extension of the knees, ankles, and toes. At the gross morphology level, the spinal cord showed signs of compression at upper and lower levels related with the implanted CHO tumor. Histology revealed tumor invasion in the spinal canal that was related with deficit in the flexion and extension of the toes. The tumor showed typical CHO morphology: physaliferous cells filled with vacuolated cytoplasm of mucoid matrix.

Conclusions. We have developed a novel orthotopic human CHO model in rats. This model reproduces cardinal clinical signs such as locomotor and sensory deficits present in human patients. To our knowledge, this is the first orthotopic animal model of human CHO. Its use and further study will be essential for pathophysiology research and the development of new therapeutic strategies.

Citation Format: Rachel Sarabia-Estrada, Alejandro Ruiz-Valls, Courtney R. Goodwin, Sagar Sha, Alfredo Quiñones-Hinojosa, Ziya L. Gokaslan, Daniel M. Sciubba. An orthotopic model of human chordoma in rats. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5149. doi:10.1158/1538-7445.AM2015-5149

  • ©2015 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 75 (15 Supplement)
August 2015
Volume 75, Issue 15 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 5149: An orthotopic model of human chordoma in rats
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 5149: An orthotopic model of human chordoma in rats
Rachel Sarabia-Estrada, Alejandro Ruiz-Valls, Courtney R. Goodwin, Sagar Sha, Alfredo Quiñones-Hinojosa, Ziya L. Gokaslan and Daniel M. Sciubba
Cancer Res August 1 2015 (75) (15 Supplement) 5149; DOI: 10.1158/1538-7445.AM2015-5149

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 5149: An orthotopic model of human chordoma in rats
Rachel Sarabia-Estrada, Alejandro Ruiz-Valls, Courtney R. Goodwin, Sagar Sha, Alfredo Quiñones-Hinojosa, Ziya L. Gokaslan and Daniel M. Sciubba
Cancer Res August 1 2015 (75) (15 Supplement) 5149; DOI: 10.1158/1538-7445.AM2015-5149
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Tumor Biology

  • Abstract SY34-04: Do we need to know what pO2 hypoxia is
  • Abstract SY28-04: Rational incorporation of novel agents into multimodality treatment of glioma and neuroblastoma
  • Abstract SY28-02: Connections in the BRCA1-BRCA2 pathway of homologous recombination: Implications for breast cancer development and treatment
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Other Animal Species and Cell Models of Cancer

  • Abstract 5134: Pharmaceutical effect of vitamin C (ascorbate) on B16 melanoma in vitro and in vivo
  • Abstract 5127: The most common mistakes in cancer cell pharmacology
  • Abstract 5152: Zebrafish models of myeloid malignancies produced through tet2 and asxl1 genomic editing
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement